Epidemiologic Determinants of Change in Cardiac Structure and Function (ECHO-SOL 2)

心脏结构和功能变化的流行病学决定因素 (ECHO-SOL 2)

• 批准号: 9113878
• 负责人: Carlos Jose Rodriguez
• 金额: $ 83.99万
• 依托单位: WAKE FOREST UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2019-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9113878
• 关键词: Accounting; Acculturation; Adult; Age; Area; Body mass index; Cardiac; Cardiovascular Diseases; Chronic Disease; Chronic stress; Clinical; Clinical Trials; Cohort Studies; Collaborations; Complement; Contracts; Data; Databases; Development; Diabetes Mellitus; Echocardiography; Education; Epidemic; Epidemiologic Factors; Epidemiologic Studies; Framingham Heart Study; Functional disorder; Funding; Future; Geometry; Goals; Health Planning; Heart Abnormalities; Heart Diseases; Heart failure; High Prevalence; Hispanic Community Health Study/Study of Latinos; Hispanics; Hypertension; Income; Individual; Investigation; Latino; Learning; Left; Left Ventricular Ejection Fraction; Left Ventricular Hypertrophy; Left Ventricular Mass; Letters; Link; Measures; Mechanics; Myocardial; Myocardial dysfunction; Not Hispanic or Latino; Obesity; Participant; Pathway interactions; Pattern; Phenotype; Prediabetes syndrome; Prevalence; Prevention; Process; Public Health; Reporting; Research; Research Personnel; Resources; Risk; Risk Factors; Signal Transduction; Social support; Socioeconomic Factors; Staging; Structure; Study of Latinos; Techniques; Tissues; Torsion; Translating; United States; United States National Institutes of Health; Ventricular; Vulnerable Populations; Work; base; cardiovascular health; cardiovascular risk factor; cohort; cost effective; ethnic minority population; follow-up; high risk; innovation; mortality; novel; novel strategies; population based; prehypertension; psychosocial; public health relevance; racial and ethnic; residence; screening; socioeconomics; trend

 DESCRIPTION (provided by applicant): Hispanics are under-represented in heart failure (HF) clinical trials and epidemiologic studies. The contract funded Hispanic Community Health Study/Study of Latinos (HCHS/SOL) did not include a provision for a baseline echo exam. The NIH-funded Echocardiographic Study of Latinos (ECHO-SOL; PI Dr. Rodriguez) helped fill this critical gap. We successfully performed echo exams using techniques such as tissue Doppler and speckle tracking in a representative subset of the HCHS/SOL baseline cohort. Our preliminary data show that despite a relatively young age of 56+0.4 years, the prevalence of left ventricular (LV) hypertrophy, abnormal LV geometry and diastolic dysfunction is higher among Hispanics than previously reported in non- Hispanic whites. In addition, acculturation, a factor relevant to Hispanics but understudied in relation to HF risk, was significantly associated with a higher prevalence of cardiac structural and functional abnormalities. In HF, progression from Stage A (HF risk factors alone) to Stage B (abnormalities of cardiac structure and function) to Stage C (clinical symptomatic HF; either with preserved [HFpEF] or reduced EF [HFrEF]) is an incredibly important process. There is a shortage of longitudinal cohort studies on progression across the HF stages in racial/ethnic minorities. Longitudinal data are essential to determine if distinct patterns of change in cardiac phenotypes from stage A to B HF can identify individuals on a trajectory towards developing clinical HF. Cohorts of non-Hispanics, such as the FHS and CHS, show that changes in cardiac echo parameters within a 4-5 year period can predict incident HF. Our ECHO-SOL data show the feasibility of assessing cardiac progression with serial echo exams in our unique cohort. However, the current contract funded HCHS/SOL 2nd exam does not include echo exams on ECHO-SOL participants. Thus, we propose to leverage the unique resources of ECHO-SOL and the HCHS/SOL 2nd exam in order to repeat a high quality echo (ECHO-SOL 2) in the ECHO-SOL cohort on average five years post- baseline. The overall goal is to determine how the transition in traditional HF risk factors impacts longitudinal change of cardiac abnormalities by assessing serial change in echo parameters in relation to the rich clinical, sociocultural, socioeconomic and psychosocial HCHS/SOL database. ECHO-SOL 2 represents an innovative and cost-effective approach to advance our understanding of the links between progression of HF risk factor with progression of abnormal cardiac structure and function. ECHO-SOL 2 will identify patterns of HF risk factor progression and the trajectory of early cardiac dysfunction that can differentiate Hispanic adults as more or less likely to develop HF; utilizing the conjoint contributions of conventional assessment of cardiac structure and systolic / diastolic function with more novel echo measures (LV strain and twist). ECHO-SOL 2 will facilitate the screening and identification of Hispanics who are at greatest HF risk, and can then be targeted for aggressive risk factor control to lower the burden of clinical HF in this vulnerable population.

 描述(由申请人提供)：拉美裔在心力衰竭(HF)临床试验和流行病学研究中的代表性不足。合同资助的西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)不包括基线回声检查的规定。美国国立卫生研究院资助的拉丁裔超声心动图研究(Echo-Sol；Pi Rodriguez博士)帮助填补了这一关键空白。我们成功地在HCHS/SOL基线队列的代表性子集中使用组织多普勒和斑点跟踪等技术进行了回声检查。我们的初步数据显示，尽管西班牙裔美国人的年龄相对较小(56±0.4岁)，但拉美裔美国人左心室肥厚、左室几何形状异常和舒张期功能障碍的患病率高于之前报道的非西班牙裔白人。此外，文化适应是一个与拉美裔相关但与心力衰竭风险相关的研究不足的因素，与心脏结构和功能异常的发生率显著相关。在HF中，从A阶段(仅有HF危险因素)到B阶段(心脏结构和功能异常)再到C阶段(临床症状性HF；无论是保留的[HFpEF]还是降低的EF[HFrEF])是一个极其重要的过程。缺乏关于种族/族裔少数群体中心衰阶段进展的纵向队列研究。纵向数据对于确定从A期心衰到B期心衰的不同心脏表型变化模式是否可以确定个体是否处于发展为临床心衰的轨迹上是至关重要的。非西班牙裔人群，如FHS和CHS，表明心脏回声参数在4-5年内的变化可以预测心力衰竭的发生。我们的ECHO-SOL数据显示了在我们独特的队列中使用系列ECHO检查评估心脏进展的可行性。然而，目前合同资助的HCHS/SOL第二次考试不包括对ECHO-SOL参与者的ECHO检查。因此，我们建议利用ECHO-SOL和HCHS/SOL第二次考试的独特资源，以便在基线后平均五年重复ECHO-SOL队列中的高质量ECHO(ECHO-SOL2)。总体目标是确定传统心力衰竭风险因素的转变如何影响纵向 通过评估与丰富的临床、社会文化、社会经济和心理社会HCHS/SOL数据库相关的回声参数的系列变化，来评估心脏异常的变化。ECHO-SOL2是一种创新的、经济有效的方法，可以促进我们对心力衰竭危险因素进展与心脏结构和功能异常进展之间的联系的理解。ECHO-SOL2将确定心衰危险因素进展的模式和早期心功能障碍的轨迹，可以区分拉美裔成年人或多或少有可能发展为心衰；利用心脏结构和收缩/舒张期功能的常规评估与更新的回声测量(LV应变和扭转)的联合贡献。ECHO-SOL2将有助于筛选和识别具有最大心力衰竭风险的拉美裔人，然后可以针对积极的风险因素进行控制，以降低这一脆弱人群的临床心力衰竭负担。